American Journal of Physiology-Lung Cellular and Molecular PhysiologyMolecular BiologyPeer-reviewed journal article
Immunomodulation of the Innate Host Response by Mesenchymal-Derived Versican during Influenza A Virus Infection
Jourdan E. BruneiD, Mary Y. ChangiD, Fengying TangiD, Cecilia López‐MartíneziD, Stephen R. ReevesiD, Christina K. Chan, Peter Waldron, David F. BoydiD, Sina A. GharibiD, Paul G. ThomasiD, William A. AltemeieriD, Charles W. FrevertiD
Abstract
Viral and bacterial lung infections place a significant burden on public health. Versican, an extracellular matrix (ECM) chondroitin sulfate proteoglycan, coordinates the innate immune response in multiple experimental models. Versicans potential as an immunomodulatory molecule makes it a promising therapeutic target for controlling the hosts immune response to lung infection. However, versicans contribution to lung inflammation, injury, and immune cell activity during influenza A virus (IAV) infection represents a critical knowledge gap. To address our central hypothesis that mesenchymal-derived versican is pro-inflammatory and enhances the innate immune response to IAV infection, we generated a tamoxifen-inducible mouse deficient in mesenchymal-derived versican (B6. Col1a2-CreERT+/-/Vcantm1.1Cwf, Col1a2/Vcan-/-). We report that mesenchymal-derived versican plays a critical role in neutrophil, monocyte, and dendritic cell migration into the lungs and airways early in IAV infection. Intriguingly, mesenchymal-derived versican deficiency had the most substantial negative impact on neutrophil emigration into the lungs. We found that neutrophils were less adhesive to the ECM of Col1a2/Vcan-/- mouse lung fibroblasts (mLFs), which had a significant decrease in versican compared to wild-type mLFs. Additionally, Col1a2/Vcan-/- mLFs treated with poly(I:C) in vitro have reduced cell-associated hyaluronan. These findings suggest that fibroblast-derived versican is necessary for adhesion to lung fibroblasts by neutrophils as they transit into the lung interstitium and airways from the pulmonary vasculature. Our findings demonstrate that mesenchymal-derived versican is a key regulator of the early host immune responses to IAV. NEW & NOTEWORTHYWe report the novel finding that mesenchymal-derived versican is critical for neutrophil, monocyte, and dendritic cell migration into the lungs and airways early in influenza A virus infection. Additionally, a differentiated neutrophil-cell line is less adherent to versican-deficient fibroblasts, and versican-deficient fibroblasts have significantly reduced cell-associated hyaluronan (HA) content in vitro. These findings suggest that mesenchymal-derived versican and cell-associated HA are necessary for the adhesion of neutrophils and monocytes to lung fibroblasts.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 31%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Influenza-induced activation of recruited alveolar macrophages during the early inflammatory phase drives lung injury and lethality
C. M. Koch, K. Anekalla, … K. M. Ridge·bioRxiv·Jun 8, 2020
- The pro-inflammatory response to influenza A virus infection is fueled by endothelial cells
L. Bauer, L. Rijsbergen, … D. van Riel·bioRxiv·Aug 19, 2022
- Post-Influenza Environment Reduces Aspergillus fumigatus Conidia Clearance and Facilitates Invasive Aspergillosis In Vivo
K.-W. Liu, M. S. Grau, … J. J. Obar·bioRxiv·Oct 14, 2022
- Evidence for vagal sensory neural involvement in influenza pathogenesis and disease
Nathalie A. J. Verzele, Brendon Yew Loong Chua, … Alice E. McGovern·PLoS PathogensPeer-reviewed·Apr 16, 2024
- Vagal TRPV1+ sensory neurons regulate myeloid cell dynamics and protect against influenza virus infection
Nicole Almanzar, Daping Yang, … Isaac M. Chiu·Science ImmunologyPeer-reviewed·Aug 1, 2025
- Lung structural cell dynamics are altered by influenza virus infection experience leading to rapid immune protection following viral re-challenge
Julie C. Worrell, Kerrie E Hargrave, … Megan K. L. MacLeod·Nature CommunicationsPeer-reviewed·Aug 1, 2025